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Abstract
Background: The arterial hypertension varies in according to the circadian cycle, presenting physiologic fall of blood 
pressure (BP) during sleep (dipping). The absence of this fall or its increase associates to higher incidence of target-
organ damages.
Objective: To analyze the prevalence of dipping in hypertensive individuals, to correlate dipping to the blood pressure 
levels, clinic, and socio-demographic factors, and biochemical characteristics and to associate it cardiovascular events 
(stroke and myocardial infarction).
Methods: Hypertensive individuals were submitted to the ambulatory blood pressure monitoring. Presence of dipper 
was defined as fall ≥10% of the systolic BP of the day for sleep.
Results: 6 evaluated patients were divided in dippers (D, n=5) and nondippers (ND, n=0). Between the groups 
there was not significant difference to the age, sex, race, time of hypertension, glycemia, LDL-cholesterol, total cholesterol, 
triglycerides, schooling, smoking, and history of diabetes. D presented BP higher than the ND during the day and 
lower during sleep. ND had higher body mass index (BMI) (p=0.077), lower level of HDL-cholesterol (p=0.089), 
and higher pulse pressure during sleep (p=0.005). History of stroke alone (p=0,046) and combined with myocardial 
infarction (p=0.0) were more frequent in nondippers individuals. In the logistic regression, only ND was associated 
independently with stroke or myocardial infarction.
Conclusion: ND was associated in an independent way with the target-organ damages analyzed, what demonstrates its 
importance and strengthens the necessity of more aggressive treatment with objective to reach BP goals e, consequently, 
to prevent the development of new cardiologic and cerebrovascular events. (Arq Bras Cardiol 00; 94() : 74-80)
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Introduction
Blood pressure (BP) varies according to the interaction 
between neural-humoral, behavioral and environmental 
factors. One of the complementary exams capable of assessing 
this pressure pattern in a 24-hour period is the ambulatorial 
blood pressure monitoring (ABPM), which allows the indirect 
and intermittent register of BP, thus enabling the understanding 
of its variation profile at vigil and sleep periods. According 
to the Brazilian guidelines on ABPM, systemic arterial 
hypertension (SAH) is characterized by values superior to 
130/80 mmHg1 during 24-hour period. Nowadays, there is 
evidence that the values obtained by ABPM prognosticate 
better the most significant cardiovascular events, such as 
myocardium infarction and stroke, in comparison to the values 
found in consultation rooms2-6.
Among the parameters assessed by ABPM, some deserve to 
be emphasized. In analysis of the Syst-Eur study6, the variable 
which showed better correlation to the main cardiovascular 
events was systolic blood pressure during sleep, followed by 
24-hour and vigil systolic blood pressure. Another variable 
that deserves to be emphasized is the pressure drop which 
occurs in the vigil to sleep period, called nocturnal dipping 
(ND). With regard to the prognostic bound to this variable, 
whose normality value is a minimum 10% reduction of BP 
during sleep period in relation to vigil, it is known that there 
is an inverse correlation of BP during sleep and cardiovascular 
outcomes, even in the presence of normal mean values of 
pressure obtained by ABPM4.
On account of the importance bounded to the gauging of 
24-hour pressure levels and the worse cardiovascular prognosis 
represented by the individual without ND, this study had the 
following objectives: to assess the prevalence of ND among 
individuals with SAH, to correlate ND to pressure levels, 
clinical variables, sociodemographic and biochemical factors 
and to associate them with cardiovascular events (stroke and 
myocardium infarction). 
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Methods
A group of 163 hypertensive individuals, followed-up in 
a specialty ambulatory, were assessed and, later on, divided 
into groups with and without nocturnal dipping (dipper and 
non-dipper). The patients presented SAH diagnosis for at 
least three years. All participants signed the informed consent, 
which was previously approved by the Ethics Committee of 
the institution. 
For the assessment of comorbidities, data regarding 
the presence of diabetes mellitus (DM), history of stroke, 
dislipidemia (DLP), medicines in usage, body mass index 
[IMC=kg/height (m2)], school degree, sex and other risk factors 
or necessary information obtained from the medical record 
were investigated. 
The patients who already presented diagnosis were 
considered diabetic individuals due to the presence of at least 
two fast glycemia dosages ≥ 126 mg/dL or to altered glucose 
oral tolerance test (OGTT)7. Patients who had OGTT in the 
range of glucose intolerance, that is, glycemia of two hours after 
taking dextrosol with values between 140 and 199 mg/dL, were 
studied in the non-diabetic group, even when under treatment 
with metformin (three patients), which is recommended for 
such cases8. Analysis of stroke episodes was carried out based 
on clinical history, presence of sequel and events previously 
identified in the medical record. MI diagnosis was based on 
clinical history and confirmed by analysis of medical records that 
showed previous enzymatic alterations (troponin and CK-MB), 
electrocardiographic alterations suggestive of coronary ischemia 
and proper treatment for this situation. 
DLP was identified by total cholesterol dosages (TC), high-
density lipoprotein cholesterol fraction (HDL-c) and triglycerides 
(TG) after 12-hour fasting9. The following reference values were 
adopted: TC<200 mg/dL, HDL-c > 40 mg/dL, low-density 
lipoprotein cholesterol fraction (LDL-c) <130 mg/dL and TG 
< 150 mg/dL. LDL-c fraction was calculated by means of the 
formula: LDL-c = TC - HDL-c - TG/5 (for TG<400 mg/dL)10. 
Individuals with alterations in the aforementioned parameters 
and/or those who were under treatment with HMG-CoA redutase 
inhibitors or other hypolipemic medicines were considered as 
patients with dislipidemia. 
The values of systolic (SBP) and diastolic blood pressure 
(DBP) were obtained from 24-hour ABPM, as mean values 
obtained in 24 hours (_m), vigil (_v) and sleep (_s) periods 
were considered in the analysis. Pulse pressure (PP) was 
calculated with the mean values of SBP and DBP during the 
assessed periods (24 hours, vigil and sleep) in the formula PP 
= SBP – DBP. ND was standardized as drop ≥10% of SBP 
in the period of vigil to sleep. The values of ≤ 130/80 within 
24 hours, ≤ 135/85 during vigil and ≤ 120/70 mmHg during 
sleep were considered normal1.
Spacelabs 90207 with its software for equipment 
programming and written reports emission was used. The 
installation of the equipment was made during the day, and 
the patient remained with it for a 24-hour period. The process 
of monitoring was carried out in dais that represented the 
patients’ daily activities. The equipment was programmed to 
register BP measurements every 15 minutes during vigil and 
every 20 minutes during sleep. All participants were instructed 
as part of the exam protocol and registered their daily 
activities, meal, waking up and sleeping timetables, besides 
medications horary and presence of symptoms. Therefore, 
the definitions of vigil and sleep periods were based on the 
patients’ timetables. 
The calculated size of the sample, admitting α deviation 
of 1% as to reject the hypothesis of nullity, was 47. For the 
comparison between groups, the software GraphPad Instat 
3.0 was used, and the Fisher’s Exact test and Mann-Whitney 
test were applied for categorical and continuum variables, 
respectively. The multivariate logistic regression model was 
applied as to identify variables from the multivariate analysis 
that were statistically significant between groups (BMI, HDL-
c and PP_s) and significantly associated with the studied 
cardiovascular events. The deviation of α at 5% with level of 
significance of p<0.05 was adopted. 
Results
The general profile of the studied population may be 
observed on Table 1. The sample was composed by individuals 
with longtime-diagnosed SAH, whose values of BMI, waist 
circumference, fast glycemia and mean 24-hour BP were 
superior to the established limit values. 
The studied casuistry consisted of 163 individuals with 
mean age of 60.6 ± 11.6 years old and time of SAH diagnosis 
of 15.8 ± 10.8 years. After ABPM analysis, the studied 
individuals were divided in Dipper (n=53, patients with 
Table 1 - Basal profile of the studied population
Variable Mean ± SD
Age (years old) 60.6 ± 11.6
SAH time (years) 15.8 ± 10.8
BMI (Kg/m2) 30.3 ± 5.6
School degree (years of study) 4.0 ± 3.2
Waist circumference (cm) 107.0 ± 14.2
SBP_m (mmHg) 134.9 ± 18.9
DBP_m (mmHg) 80.2 ± 11.0
SBP_v (mmHg) 138.0 ± 17.0
DBP_v (mmHg) 82.6 ± 11.4
SBP_s (mmHg) 129.0 ± 17.4
DBP_s (mmHg) 73.3 ± 10.7
Fast glycemia (mg/dL) 117.1 ± 53.0
HDL-c (mg/dL) 54.4 ± 14.7
LDL-c (mg/dL) 110.2 ± 32.5
Triglycerides (mg/dL) 136.6 ± 73.0
Total cholesterol (mg/dL) 191.3 ± 40.2
Number of anti-hypertensive medications 2.7 ± 0.9
SBP dipping (%) 6.4 ± 7.4
BMI - body mass index; SB -, systolic blood pressure; DBP - diastolic blood 
pressure; _m - mean 24-hour pressure value; _v - pressure value during 
vigil; _s - pressure value during sleep.
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SAH and present ND) and Non-dipper (n=110, hypertensive 
individuals without ND). Dipper Group was composed of 29 
women and 24 men, while Non-dipper Group comprised 
62 women and 48 men. Groups did not differ (p>0.05) with 
regard to individuals’ mean age, SAH time, school degree 
and waist circumference (Table 2). With regard to BMI, ND 
individuals presented lower mean values in comparison to 
hypertensive patients without ND (29.2 ± 5.0 x 30.9 ± 5.7, 
p=0.0377). 
Based on ABPM, it was observed that Dipper Group 
presented pressure levels higher than those of Non-dipper 
Groups during vigil period for SBP (141.6 ± 16.4 x 136.2 ± 
17.0, p=0.0232) and for DBP (86.5 ± 10.4 x 80.6 ± 11.5, 
p=0.0003). During sleep period, Dipper Groups presented 
mean values lower than those of Non-dipper Group for SBP 
(122.1 ± 14.1 x 132.4 ± 17.9, p=0.0001) and DBP (70.2 ± 
8.6 x 74.8 ± 11.3, p=0.0113). Though pressure levels during 
24-hour period followed a tendency of higher mean values in 
Dipper Group, they presented significant differences only for 
DBP (82.5 ± 9.4 x 79.0 ± 11.5, p=0.0065), while values for 
Table 2 – Comparison between continuum variables of groups with 
and without ND by Mann-Whitney test
Variable Dipper (n=53) Non-dipper (n=110) p-value
Age (years old) 60.4 ± 12.4 60.6 ± 11.3 NS
SAH time (years) 15.1 ± 12.1 16.1 ± 10.1 NS
BMI (Kg/m2) 29.2 ± 5.0 30.9 ± 5.7 0.0377
School degree (years 
of study) 3.7 ± 3.0 4.2 ± 3.4 NS
Waist circumference 
(cm) 106.9 ± 11.2 107.1 ± 15.5 NS
SBP_m (mmHg) 134.1 ± 22.6 135.4 ± 16.9 NS
DBP_m (mmHg) 82.5 ± 9.4 79.0 ± 11.5 0.0065
PP_m (mmHg) 54.2 ± 13.3 56.3 ± 12.5 NS
SBP_v (mmHg) 141.6 ± 16.4 136.2 ± 17.0 0.0232
DBP_v (mmHg) 86.5 ± 10.4 80.6 ± 11.5 0.0003
PP_v (mmHg) 55.3 ± 11.6 55.6 ± 12.4 NS
SBP_s (mmHg) 122.1 ± 14.1 132.4 ± 17.9 <0.0001
DBP_s (mmHg) 70.2 ± 8.6 74.8 ± 11.3 0.0113
PP_s (mmHg) 51.9 ± 10.9 57.6 ± 13.5 0.0025
Fast glycemia (mg/dL) 106.3 ± 32.1 122.4 ± 60.0 NS
HDL-c (mg/dL) 57.4 ± 14.2 52.9 ± 14.8 0.0189
LDL-c (mg/dL) 111.7 ± 29.1 109.4 ± 34.1 NS
Triglycerides (mg/dL) 130.9 ± 62.6 139.5 ± 77.7 NS
Total cholesterol (mg/dL) 195.3 ± 37.2 189.4 ± 41.7 NS
Number of anti-
hypertensive 
medications
2.6 ± 0.9 2.7 ± 0.9 NS
BMI - body mass index; SBP - systolic blood pressure; DBP - diastolic 
blood pressure; PP - pulse pressure; _m - mean 24-hour pressure value; 
_v - pressure value during vigil; _s - pressure value during sleep; NS - Non-
significant (p>0.05).
SBP were not significant (p>0.05). When PP of both groups 
was analyzed, we observed that the individuals from Dipper 
Group presented lower PP during sleep (51.9 ± 10.9 x 57.6 
± 13.5, p=0.0025) in comparison to Non-dipper Group. 
Such relation was not observed for PP during vigil and within 
the 24-hour period. 
Mean HDL-c was higher in patients with ND in comparison 
to the mean of individuals without it (57.4 ± 14.2 x 52.9 ± 
14.8, p=0.0189). Mean glycemia, TC, LDL-c and TG did not 
present statistically significant differences between groups. 
After analyzing qualitative variables (Table 3), we verified that 
groups did not differ (p>0.05) with regard to sex, skin color, 
smoking (5.6 versus 6.4%), sedentarism (58.5 versus 50.0%), 
MI history (1.9 versus 5.8%) in Dipper and Non-dipper Groups, 
respectively. Though DM and DLP histories have not presented 
significant p-value, both conditions were more frequent in ND 
individuals. Groups did not differ either regarding the main 
anti-hypertensive medications (diuretic, angiotensin-converting 
enzyme inhibitor, AT1 angiotensin II receptor blocker, calcium 
channel blockers and beta blockers). Stroke history (RR=1.16 
95%CI 1.00-1.33), statin usage (RR=1.36 95%CI 1.07-1.72), 
hypoglycemiant (RR=1.27 95%CI 1.01-1.59) and associate 
lesions in target-organs (MI or stroke) (RR=1.19 95%CI 1.02-
1.39) were related to ND absence. 
As groups differed in some clinical characteristics, the 
logistic regression analysis was carried out as we used the 
presence of lesions in target-organs as dependent variable 
(stroke and MI) and as independent variables all clinical 
variables, including nocturnal dipping. BMI, HDL-c and PP_s 
did not constitute factors associated with stroke and MI risk. 
Only absence of nocturnal dipping presented independent 
correlation to the presence of assessed lesions in target-organs 
(Table 4). 
Discussion
In the present study, there was a high prevalence of 
attenuation or absence of nocturnal dipping (67.5%). ND 
attenuation was associated with the presence of other 
cardiovascular risk factors (obesity and lower HDL-c) and also 
with a higher frequency of lesion in target-organ. Studies on 
the prevalence of cardiovascular and cerebral events varies 
greatly in the specific literature (Table 5), reaching a frequency 
of 37.5 to 64.2%11-21 under several factors’ influence, like the 
definition of sleep and vigil periods22.
In our sample, ND individuals presented mean pressure 
superior to those presented by individuals without ND 
during vigil and inferior during sleep. However, when the 
24-hour period was assessed, this behavior pattern was not 
observed. These findings, in general, differ from those found 
in literature14-16,18,19.
Torun et al14, after analyzing hypertensive patients with 
similar pressure levels during ambulatorial gauging and that 
never received treatment, observed that patients without ND 
presented higher mean systolic and diastolic pressures within 
24 hours, higher SBP values in vigil and higher SBP and DBP 
values during sleep in comparison to patients with ND. The 
authors associated these findings with the high prevalence of 
lesions in target-organs in the mentioned group, a result which 
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Table 3 - Comparison between qualitative variables of groups with and without ND by Fisher’s exact test
Variable Presence of ND (n=53)
Absence of ND 
(n=110) OR 95%CI  p-value
Females – no (%) 29 (54.7) 62 (56.3) 1.038 0.72-1.49 NS
Smoking - no (%) 3 (5.6) 7 (6.4) 1.008 0.92-1.09 NS
White skin - no (%) 29 (54.7) 62 (56.3) 1.014 0.69-1.47 NS
Sedentarism - no (%) 31 (58.5) 55 (50.0) 0.837 0.57-1.21 NS
DM history - no (%) 15 (28.3) 42 (38.2) 1.16 0.92-1.45 NS
Stroke history - no (%) 6 (11.3) 26 (23.6) 1.16 1.00-1.33 0.046
MI history - no (%) 1 (1.9) 6 (5.8) 1.03 0.97-1.10 NS
DLP history - no (%) 22 (26.4) 59 (54.1) 1.27 0.94-1.73 NS
Statin usage - no (%) 14 (26.4) 50 (45.9) 1.36 1.07-1.72 0.013
Usage of hypoglycemiant medications - no (%) 14 (26.4) 46 (42.2) 1.27 1.01-1.59 0.036
Usage of diuretic medications - no (%) 45 (84.9) 94 (86.2) 1.11 0.44-2.82 NS
Usage of ACEI or ARB - no (%) 45 (84.9) 90 (82.6) 0.842 0.34-2.07 NS
Usage of CCB - no (%) 28 (52.3) 56 (51.4) 0.943 0.49-1.82 NS
Usage of beta blockers - no (%) 14 (26.4) 38 (34.9) 1.49 0.72-3.08 NS
MI or stroke history - no (%) 7 (13.2) 30 (27.3) 1.19 1.02-1.39 0.032
DM - diabetes mellitus; MI - myocardium infarction; DLP - dislipidemia; ACEI - angiotensin-converting enzyme inhibitors; ARB - AT1 angiotensin II receptor blockers; 
CCB - calcium channel blockers; RR - relative risk; CI - confidence interval; NS - Non-significant (p>0.05).
is similar to those observed by Anan et al12, who emphasized 
the importance of the method chosen for the investigation of 
hypertensive patients. 
PP seems to be an independent marker of cardiovascular 
mortality, mainly among individuals older than 50 years old and 
with history of myocardium infarction, cardiac insufficiency 
and stroke23. The arterial rigidity and the reflection of pulse 
wave are the greatest determinant factors for PP elevation 
due to aging. An increase in the arterial rigidity may also 
elevate the risk for coronary events due to rapid return of 
pulse wave reflected at the end of systole and the risk for 
cerebrovascular events due to a modification in the arteries’ 
walls and development of atherosclerotic plaques24. In our 
sample, composed by individuals with mean age superior 
to 60 years old, we observed higher statistically significant 
PP in Non-dipper Group during sleep (57.6 mmHg), but no 
statistical significance in the other periods. According to the IV 
Brazilian directive for ABPM, the value of 53 mmHg is praised 
for PP as a limit which is superior to normality1. This value was 
initially showed by Verdecchia et al25, who found a higher risk 
for cardiovascular events when PP was superior to 53 mmHg 
after evaluating more than 2 thousand patients through ABPM. 
However, despite the fact that Non-dipper Group had higher 
PP, the logistic regression model did not show association with 
cardiovascular events in the present study.
After the analysis of sociodemographic factors, we pointed 
out in our sample the absence of association between ND 
and the remaining variables (age, SAH time, school degree, 
waist circumference, genre, race, smoking and sedentarism), 
which was confirmed by other studies12,14,15,26. Other authors 
observed that individuals without ND were older16,18,19 
and that this condition occurs preferentially in non-white 
people19. In the current study, BMI was higher in individuals 
without ND (30.9 ± 5.7 x 29.2 ± 5.0, p=0.0377), fact also 
observed by Kotsis et al27 in 3,216 patients without previous 
anti-hypertensive treatment. These authors showed a direct 
relation between higher BMI and higher mean pressure for 
ABMP, and 55% of the individuals with normal weight (normal 
BMI) presented ND, while only 35% of the obese individuals 
presented the same condition (p<0.05). Others, however, 
did not find such association12,14-16,19. In our sample, after 
the logistic regression model, we observed that BMI was not 
correlated to a higher risk for stroke or MI in ND patients. 
After the biochemical dosages, we found that, except for 
the higher levels of HDL-c in ND patients, the remaining 
variables did not present statistical significance, findings that 
are similar to those observed in other studies15,16. Despite 
the lower HDL-c in non-dipper patients, there was no 
correlation to higher risk of lesions in target-organs. Alterations 
found in the levels of uric acid14,16, serum creatinine16,18, 
glycemia12,18 and triglycerides15,16 in patients without ND 
make their interpretation difficult due to the differences 
found between the studied populations as well as to the 
influence of medications on these biochemical parameters. 
Though we observed a higher prevalence of diabetic patients 
in the Non-dipper Group (38.2 versus 28.3%), this value was 
not statistically significant, which opposes to the findings of 
Björklund et al28, who found higher frequency of individuals 
without ND in a diabetic subpopulation. The homogeneous 
distribution of diabetes among both groups eliminates a 
possible confusing factor, for the presence of diabetes could 
interfere in the nocturnal dipping pattern. The frequent use 
of hypoglycemiant medications in the group without ND 
may be explained by the presence of a greater number of 
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Table 5 – Prevalence of nocturnal dipping in transversal studies
Authors Sample composition Number of individuals ND prevalence 
Kario et al11 Individuals with sustained hypertension and silent and/or clinically manifested stroke 575 56.8%
Anan et al12 Hypertensive patients with attenuate nocturnal dipping and high risk for cardiovascular events 103 55.3%
Torun et al14 Hypertensive individuals that never received treatment 67 64.2%
Davidson et al15 Non-diabetic individuals without use of anti-hypertensive medication 106 55.6%
Davidson et al16 Hypertensive patients with attenuate nocturnal dipping and deterioration of renal function 322 42.5%
Jerrard-Dunne et al17 Hypertensive individuals that never received treatment 314 62.7%
Brotman et al19 Hypertensive patients with attenuate nocturnal dipping and high risk for obit due to cardiovascular events 621 42.0%
Shinohata et al21 Hypertensive individuals that never received treatment 90 60.0%
AMBP - ambulatorial monitoring of blood pressure; ND - nocturnal dipping.
Table 4 – Logistic regression model for stroke and MI in non-dipper 
patients
Variables β Standard error
Odds Ratio 
(95%CI)  p-value
Non-dipper 11.502 0.5764 3.16 (1.02-9.78) 0.046
BMI -0.0586 0.1022 0.94 (0.77-1.15) NS
HDL-c -0.00805 0.04166 0.99 (0.91-1.07) NS
PP_s -0.00876 0.06409 0.99 (0.87-1.12) NS
MI - myocardium infarction; BMI - body mass index; CI - confidence interval; 
NS - non-significant (p>0.05).
diabetic patients, although there was no statistically significant 
difference among them. 
In the current paper, stroke history (p=0.046) and the 
association with MI or stroke (p=0.032) were statistically 
significant in patients without ND. Possible reasons for these 
findings may be found in the history of lesions in target-organs 
of hypertensive patients, that is, left ventricle hypertrophy, 
microalbuminury, renal dysfunction and cerebrovascular 
disease are more prevalent in individuals without ND1,14,18. 
Ohkubo et al29 assessed 1,542 individuals older than 40 years 
old who were followed-up for approximately 9.2 years. The 
authors found a linear relation between nocturnal dipping 
of blood pressure and mortality, and each 5% of reduction 
of SBP and DBP drop, the risk for cardiovascular mortality 
would increase in 20%. Even in the presence of normal mean 
24-hour pressure levels (≤130/80 mmHg), the attenuation 
of nocturnal dipping of blood pressure were associated with 
an increase in the risk for cardiovascular death. Kario et al11 
followed-up a Japanese population of 575 individuals of ≥50 
years old who were divided into groups according to nocturnal 
dipping of SBP. After a 41 months average, they observed 
that the incidence of stroke was of 12% among individuals 
with accentuate nocturnal dipping (≥20%), 6.1% among 
individuals with ND between 10 and 20%, 7.6% among 
individuals without ND (≥0% and <10%) and 22% among 
patients with nocturnal dipping of blood pressure. 
The mechanisms responsible for this abnormal variation 
of arterial pressure remain unknown, though there is strong 
evidence of a possible involvement of compromising in the 
autonomic balance, which leads to a sympathetic hyperactivity 
during sleep period that may alter circadian rhythm, common 
occurrence among patients with sleep apnea syndrome30. 
Another factor that seems to exert influence on ND 
phenomenon is sodium ingestion31. Some studies reported 
that ND would be associated to a reduced excretion of sodium 
during vigil period32,33. Birkenhäger and van den Meiracker34 
observed that a low sleep quality, along with daily inactivity, 
represented by sedentarism, might explain the phenomenon 
of ND absence. 
Something that also deserves to be emphasized in our 
study is that mean pressure values during vigil, sleep and 
24-hour period obtained by means of ABPM were above the 
limits recommended by our guideline1. In that case, measures 
as adoption of a more rigid treatment and the modification 
of medication administration horary could contribute with 
the improvement of these individuals’ pressure profile and, 
consequently, change ND pattern35.
This previous concept that the absence of ND could be 
related to a worse cardiovascular and cerebral outcome 
has, however, exceptions and there are groups in which the 
influence of this variable deserves better elucidations, like in 
the case of individuals with previous history of cerebrovascular 
disease. Nakamura et al36 followed-up individuals with 
previous stroke history and observed that ischemic event 
recurrence rate was higher among individuals with ND and 
under anti-hypertensive treatment. Besides, the frequency 
of new events was higher among treated hypertensive and 
ND patients than among those without nocturnal dipping. 
In that special case, though controlling pressure levels is a 
effective measure for the prevention of new events37, an 
aggressive anti-hypertensive therapy may collaborate to a 
cerebral hypoperfusion and, consequently, to the aggravation 
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